Aclaris Therapeutics Cash Flow Statement (2014-2026) | ACRS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-18.01M-20.30M-22.89M-18.91M-20.99M-20.87M-29.08M-29.92M-31.82M-29.26M-1.86M-16.94M-10.99M-8.48M-97.57M-15.92M-16.39M-15.33M-21.10M-20.68M
Depreciation and Depletion (Quarter)
0.20M0.20M0.20M0.20M0.20M0.20M0.10M0.20M0.20M0.20M0.20M0.20M0.20M0.20M0.10M0.10M0.10M0.10M
Share-based Compensation (Quarter)
3.83M3.70M3.85M2.35M3.69M4.19M4.81M6.81M6.52M5.95M1.27M2.09M2.90M3.00M2.86M3.54M3.06M2.86M2.93M3.20M
Gains from Sales and Divestitures (Quarter)
1.31M1.34M1.34M0.48M0.51M0.53M0.53M0.52M0.66M0.71M0.75M0.40M0.49M0.54M1.47M0.53M0.60M0.61M1.54M0.72M
Gains from Investment Securities (Quarter)
4.80M0.03M-1.75M-1.20M5.01M0.85M1.09M1.90M0.20M0.23M-27.00M1.29M0.20M1.91M-1.30M3.86M1.50M0.10M0.40M4.32M
Asset Writedowns and Impairment (Quarter)
6.60M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)
16.70M14.70M13.71M23.20M10.82M15.38M15.29M4.74M6.43M3.68M0.01M16.60M13.20M0.01M2.97M0.74M14.00M2.16M8.60M14.68M
Cash from Operations (Quarter)
-12.22M-10.61M-17.07M-20.97M-19.67M-7.82M-19.11M-26.35M-20.65M-24.56M-6.76M-20.82M-12.32M22.00M-8.94M-13.06M-9.99M-10.93M-13.13M-18.15M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.25M0.19M0.20M0.21M0.21M0.19M0.19M0.20M0.22M0.22M0.23M0.24M0.24M0.18M0.14M0.13M0.11M0.11M0.10M0.10M
Change in Working Capital
Change in Receivables (Quarter)
0.12M-0.13M-0.19M0.01M0.00M-0.04M-0.11M0.20M-0.26M-0.09M-0.05M0.07M-0.05M0.02M-0.03M-0.07M-0.06M
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
-3.13M2.58M2.36M-1.86M-2.42M1.96M2.69M-2.16M3.23M-2.15M-0.39M1.93M-3.54M0.39M-2.97M1.66M2.44M0.38M3.96M1.51M
Change in Accured Expenses (Quarter)
3.29M-2.93M2.54M-1.85M1.67M1.45M-0.68M-1.16M0.92M6.59M5.64M-12.91M-1.46M-1.15M11.57M-11.04M0.40M1.29M1.25M-3.03M
Investing Activities
Capital Expenditures (Quarter)
0.07M0.04M0.11M-0.04M-0.07M0.60M0.55M-0.16M-0.02M0.93M0.14M-0.01M0.04M0.02M0.02M-0.07M0.01M
Change in Intangibles (Quarter)
0.83M
Change in Acquisitions & Divestments (Quarter)
16.06M14.96M26.32M44.65M49.50M35.00M48.83M54.88M70.56M49.78M7.99M16.97M34.53M17.13M17.51M29.99M25.00M19.05M15.00M20.75M
Cash from Investing Activities (Quarter)
-45.47M-37.67M-9.18M29.93M-21.22M1.22M2.70M25.80M-19.66M32.53M7.55M16.83M-0.67M2.79M-88.72M19.12M5.05M13.83M10.37M-30.93M
Financing Activities
Other financing activities (Quarter)
0.30M-0.10M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
-101.89M0.04M0.08M72.62M26.68M74.88M57.88M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
135.87M-11.57M-0.00M0.03M72.81M-0.01M0.04M-0.09M0.05M-0.06M-0.01M0.02M74.58M-0.28M-0.01M-3.04M-2.53M57.78M
Change in Cash (Quarter)
78.18M-59.84M-26.25M8.99M31.92M-6.61M-16.38M-0.56M-13.57M7.89M0.84M-4.04M-13.01M24.82M-23.08M5.79M-4.96M-0.15M-5.30M8.70M
Free Cash Flow (Quarter)
-12.22M-10.68M-17.11M-21.08M-19.63M-7.75M-19.72M-26.91M-20.50M-24.54M-7.69M-20.95M-12.31M22.00M-8.94M-13.10M-10.01M-10.96M-13.06M-18.16M
Net Cash Flow (Quarter)
78.18M-59.84M-26.25M8.99M31.92M-6.61M-16.38M-0.56M-40.32M7.89M0.84M-4.04M-13.01M24.82M-23.08M5.79M-4.96M-0.15M-5.30M8.70M